The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment

Journal of Research in Medical Sciences

Volumn 19, Issue 8, 2014, Pages 739-745

  Barekatain, Majid ^a   Askarpour, Hedyeh ^b   Zahedian, Faezeh ^b   Walterfang, Mark ^c   Velakoulis, Dennis ^c   Maracy, Mohammad Reza ^d   Jazi, Mohammad Hashemi ^e  

^a Department of Pathobiology School of Medicine   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Department of Epidemiology and Biostatistics and Behavioral Sciences Research Center ^*  (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiography; Brain volumes; Coronary artery disease; Magnetic resonance imaging; Mild cognitive impairment

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRAIN BLOOD VOLUME; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; FUSIFORM GYRUS; GENERAL HEALTH QUESTIONNAIRE; GENSINI SCORE; HUMAN; INFERIOR PARIETAL LOBULE; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCOG SCORE; PARS TRIANGULARIS; PRECUNEUS; SCORING SYSTEM; SUPERIOR TEMPORAL GYRUS; SUPRAMARGINAL GYRUS;

EID: 84911491971     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. World Health Organization. World Health Report. 2003. Shaping the Future. Geneva: World Health Organization; 2003. Open URL.
2. World Health Organization. Global Health and Aging; 2011. Available from: http://www.who.int/aging/publications/global health.pdf. [Last accessed on 2013 Nov 12].
3. Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou YY, Toga AW, et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer Dis Assoc Disord 2012;26:17-27.
4. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013;9:63-75.e2.
5. Kovacevic S, Rafii MS, Brewer JB, Alzheimer ’s Disease Neuroimaging Initiative. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2009;23:139-45.
6. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-8.
7. He J, Farias S, Martinez O, Reed B, Mungas D, Decarli C. Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol 2009;66:1393-9.
8. McEvoy LK, Edland SD, Holland D, Hagler DJ Jr, Roddey JC, Fennema-Notestine C, et al. Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease. Alzheimer Dis Assoc Disord 2010;24:269-77.
9. Whitehair DC, Sherzai A, Emond J, Raman R, Aisen PS, Petersen RC, et al. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment. Alzheimers Dement 2010;6:412-9.
10. Luck T, Luppa M, Briel S, Riedel-Heller SG. Incidence of mild cognitive impairment: A systematic review. Dement Geriatr Cogn Disord 2010;29:164-75.
11. Risacher SL, Kim S, Shen L, Nho K, Foroud T, Green RC, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci 2013;5:11.
12. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, et al. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: Stronger effect on women. JAMA Neurol 2013;70:374-82.
13. Monastero R, Palmer K, Qiu C, Winblad B, Fratiglioni L. Heterogeneity in risk factors for cognitive impairment, no dementia: Population-based longitudinal study from the Kungsholmen Project. Am J Geriatr Psychiatry 2007;15:60-9.
14. Siuda J, Gorzkowska A, Opala G, Ochudlo S. Vascular risk factors and intensity of cognitive dysfunction in MCI. J Neurol Sci 2007;257:202-5.
15. Roger VL, Jacobsen SJ, Weston SA, Goraya TY, Killian J, Reeder GS, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136:341-8.
16. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer’s disease: Inflammation, cholesterol, and misfolded proteins. Lancet 2004;363:1139-46.
17. Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004;62:920-4.
18. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer’s disease in later life: Longitudinal, population based study. BMJ 2001;322:1447-51.
19. de la Torre JC. Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 2002;33:1152-62.
20. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 1997;349:151-4.
21. Langa KM, Foster NL, Larson EB. Mixed dementia: Emerging concepts and therapeutic implications. JAMA 2004;292:2901-8.
22. Evered LA, Silbert BS, Scott DA, Maruff P, Laughton KM, Volitakis I, et al. Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery. Ann Thorac Surg 2009;88:1426-32.
23. Devapalasundarum AN, Silbert BS, Evered LA, Scott DA, MacIsaac AI, Maruff PT. Cognitive function in patients undergoing coronary angiography. Heart Asia 2010;2:75-9.
24. Rosengart TK, Sweet J, Finnin EB, Wolfe P, Cashy J, Hahn E, et al. Neurocognitive functioning in patients undergoing coronary artery bypass graft surgery or percutaneous coronary intervention: Evidence of impairment before intervention compared with normal controls. Ann Thorac Surg 2005;80:1327-34.
25. Zulli R, Nicosia F, Borroni B, Agosti C, Prometti P, Donati P, et al. Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer’s disease and mild cognitive impairment without overt coronary artery disease. Clin Neurol Neurosurg 2008;110:791-6.
26. Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging 2010;31:1894-902.
27. Martins IJ, Hone E, Foster JK, Sünram-Lea SI, Gnjec A, Fuller SJ, et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease. Mol Psychiatry 2006;11:721-36.
28. Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM, Faris P, et al. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen Psychiatry 2012;69:244-55.
29. Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging 2012;33:1979-87.
30. Shen L, Kim Q, Qi Y, Inlow M, Swaminathan S, Nho K, et al. Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net. Multimodal Brain Image Analysis. Lect Notes Comput Sci. 2011;7012:27-34.
31. Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: A review. J Am Geriatr Soc 2008;56:920-34.
32. Becker JT, Davis SW, Hayashi KM, Meltzer CC, Toga AW, Lopez OL, et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. Arch Neurol 2006;63:97-101.
33. Hämäläinen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen J, et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 2007;37:1122-31.
34. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004;25:303-10.
35. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001;71:441-7.
36. Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer’s disease. Brain 2009;132:2048-57.
37. Shi F, Liu B, Zhou Y, Yu C, Jiang T. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: Meta-analyses of MRI studies. Hippocampus 2009;19:1055-64.
38. Macdonald KE, Bartlett JW, Leung KK, Ourselin S, Barnes J, ADNI investigators. The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD. Alzheimer Dis Assoc Disord 2013;27:168-73.
39. Trivedi MA, Wichmann AK, Torgerson BM, Ward MA, Schmitz TW, Ries ML, et al. Structural MRI discriminates individuals with Mild cognitive impairment from age-matched controls: A combined neuropsychological and voxel based morphometry study. Alzheimers Dement 2006;2:296-302.
40. Almeida OP, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Flicker L. Cognitive and brain changes associated with ischaemic heart disease and heart failure. Eur Heart J 2012;33:1769-76.
41. Almeida OP, Garrido GJ, Beer C, Lautenschlager NT, Arnolda L, Lenzo NP, et al. Coronary heart disease is associated with regional grey matter volume loss: Implications for cognitive function and behaviour. Intern Med J 2008;38:599-606.
42. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606.
43. Malakouti SK, Fatollahi P, Mirabzadeh A, Zandi T. Reliability, validity and factor structure of the GHQ-28 used among elderly Iranians. Int Psychogeriatr 2007;19:623-34.
44. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
45. Walterfang M, Siu R, Velakoulis D. The NUCOG: Validity and reliability of a brief cognitive screening tool in neuropsychiatric patients. Aust N Z J Psychiatry 2006;40:995-1002.
46. Barekatain M, Walterfang M, Behdad M, Tavakkoli M, Mahvari J, Maracy MR, et al. Validity and reliability of the Persian language version of the neuropsychiatry unit cognitive assessment tool. Dement Geriatr Cogn Disord 2010;29:516-22.
47. Wheeler ME, Buckner RL. Functional-anatomic correlates of remembering and knowing. Neuroimage 2004;21:1337-49.
48. Anazodo UC, Shoemaker JK, Suskin N, St Lawrence KS. An investigation of changes in regional gray matter volume in cardiovascular disease patients, pre and post cardiovascular rehabilitation. Neuroimage Clin 2013;3:388-95.
49. Jefferson AL, Himali JJ, Beiser AS, Au R, Massaro JM, Seshadri S, et al. Cardiac index is associated with brain aging: The Framingham Heart Study. Circulation 2010;122:690-7.
50. Zheng L, Mack WJ, Chui HC, Heflin L, Mungas D, Reed B, et al. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc 2012;60:499-504.
51. Han Y, Lui S, Kuang W, Lang Q, Zou L, Jia J. Anatomical and functional deficits in patients with amnestic mild cognitive impairment. PLoS One 2012;7:e28664.
52. Menezes TL, Andrade-Valença LP, Valença MM. Magnetic resonance imaging study cannot individually distinguish individuals with mild cognitive impairment, mild Alzheimer’s disease, and normal aging. Arq Neuropsiquiatr 2013;71:207-12.
53. Hänggi J, Streffer J, Jäncke L, Hock C. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer’s disease. J Alzheimers Dis 2011;26:719-34.
54. Müller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 2005;28:1033-42.
55. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007;68:13-9.
56. Vos SJ, van Rossum IA, Verhey F, Knol DL, Soininen H, Wahlund LO, et al. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology 2013;80:1124-32. Journal of Research in Medical Sciences | August 2014 | 745